Primary membranoproliferative glomerulonephritis on the decline: Decreased rate from the 1970s to the 2000s in Japan

Clinical and Experimental Nephrology

Volumn 17, Issue 2, 2013, Pages 248-254

  Kawamura, Tetsuya ^a   Usui, Joichi ^a   Kaseda, Koji ^a   Takada, Kenji ^b   Ebihara, Itaru ^c   Ishizu, Takashi ^d   Iitsuka, Tadashi ^e   Sakai, Kentaro ^e   Takemura, Katsumi ^f   Kobayashi, Masaki ^g   Koyama, Akio ^h   Kanemoto, Katsuyoshi ⁱ   Sumazaki, Ryo ^j   Uesugi, Noriko ^a   Noguchi, Masayuki ^a   Nagata, Michio ^a   Suka, Machi ^k   Yamagata, Kunihiro ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b Tsukuba Gakuen Hospital   (Japan)

^c Mito Saiseikai General Hospital   (Japan)

^d Tsukuba Central Hospital   (Japan)

^e Department of Nephrology Ibaraki Seinan Medical Center Hospital   (Japan)

^f Takemura Nephrology Clinic   (Japan)

^g Tokyo Medical University Ibaraki Medical Center   (Japan)

^h Tsukuba Memorial Hospital   (Japan)

ⁱ SAKURA NATIONAL HOSPITAL   (Japan)

^j UNIVERSITY OF TSUKUBA   (Japan)

^k JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

Membranoproliferative glomerulonephritis; Nephrotic syndrome; Pediatrics; Primary glomerular disease

Indexed keywords

ANTITHROMBOCYTIC AGENT; CREATININE; STEROID; WARFARIN;

ADOLESCENT; ADULT; ANTICOAGULANT THERAPY; ARTICLE; CHILD; CREATININE BLOOD LEVEL; DATA BASE; DISEASE SEVERITY; ELECTRON MICROSCOPY; FEMALE; HUMAN; INCIDENCE; JAPAN; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; PROGNOSIS; RETROSPECTIVE STUDY; STEROID THERAPY; SURVIVAL RATE; AGE; AGED; BIOPSY; FACTUAL DATABASE; KAPLAN MEIER METHOD; MIDDLE AGED; ONSET AGE; PATHOLOGY; REGISTER; TREATMENT OUTCOME; YOUNG ADULT; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE;

ADOLESCENT; ADULT; AGE FACTORS; AGE OF ONSET; AGED; BIOPSY; CHILD; DATABASES, FACTUAL; FEMALE; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; HUMANS; JAPAN; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEPHROTIC SYNDROME; PROGNOSIS; REGISTRIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84891465703     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-012-0690-7     Document Type: Article

References (20)

1. Schena FP, Alpers CE. Membranoproliferative glomerulonephritis and cryogloblinemic glomerulonephritis. In: Feehally J, Floege J, Johnson RJ, editors. Comprehensive clinical nephrology. 3rd ed. Philadelphia: Mosby Elsevier; 2007. p. 243-52.
2. Yamabe H, Johnson RJ, Gretch DR, Fukushi K, Osawa H, Miyata M, et al. Hepatitis C virus infection and membranoproliferative glomerulonephritis in Japan. J Am Soc Nephrol. 1995;6(2):220-3.
3. di Belgiojoso GB, Baroni M, Pagliari B, Lavagni MG, Porri MT, Banfi G, et al. Is membranoproliferative glomerulonephritis really decreasing? Nephron. 1985;40(3):380-1.
4. Churg J, Bernstein J, Glassock RJ. Classification of glomerular diseases. In: Churg J, Bernstein J, Glassock RJ, editors. Renal disease. 2nd ed. New York: Igaku-Shoin; 1995. p. 1-23.
5. Gonzalo A, Matesanz R, Teruel JL, Ortuno J. Incidence of membranoproliferative glomerulonephritis in a Spanish population. Clin Nephrol. 1986;26(3):161.
6. Swaminathan S, Leung N, Lager DJ, Melton LJ 3rd, Bergstralh EJ, Rohlinger A, et al. Changing incidence of glomerular disease in Olmsted County, Minnesota: a 30-year renal biopsy study. Clin J Am Soc Nephrol. 2006;1:483-7.
7. Jungers P, Forget D, Droz D, Noel LH, Grunfeld JP. Reduction in the incidence of membranoproliferative glomerulonephritis in France. Proc Eur Dial Transplant Assoc Eur Ren Assoc. 1985;22:730-5.
8. Chang JH, Kim DK, Kim HW, Park SY, Yoo T-H, Kim BS, et al. Changing prevalence of glomerular diseases in Korea adults: a review of 20 years of experience. Nephrol Dial Transplant. 2009;24(8):2406-10.
9. Braden GL, Mulhern JG, O'Shea MH, Nash SV, Ucci AA Jr, Germain MJ. Changing incidence of glomerular diseases in adults. Am J Kidney Dis. 2000;35(5):878-83.
10. Study Group of the Spanish Society of Nephrology. Decreasing incidence of membranoproliferative glomerulonephritis in Spanish children. Pediatr Nephrol. 1990;4(3):266-7.
11. Iitaka K, Saka T, Yagisawa K, Aoki Y. Decreasing hypocomplementemia and membranoproliferative glomerulonephritis in Japan. Pediatr Nephrol. 2000;14(8-9):794-6.
12. West CD. Idiopathic membranoproliferative glomerulonephritis in childhood. Pediatr Nephrol. 1992;6(1):96-103.
13. Yalcinkaya F, Tumer N, Cakar N, Ekim M. Paediatric membranoproliferative glomerulonephritis is not decreasing in Turkey! Pediatr Nephrol. 1994;8(1):131-2.
14. Bahiense-Oliveira M, Saldanha LB, Andrade Mota EL, Oliveira Penna D, Toledo Barros R, Romao-Junior JE. Primary glomerular diseases in Brazil (1979-1999): is the frequency of focal and segmental glomerulosclerosis increasing? Clin Nephrol. 2004;61(2):90-7.
15. Johnson RJ, Hurtado A, Merszei J, Rodriguez-Iturbe B, Feng L. Hypothesis: dysregulation of immunologic balance resulting from hygiene and socioeconomic factors may influence the epidemiology and cause of glomerulonephritis worldwide. Am J Kidney Dis. 2003;42(3):575-81.
16. Ohmori M, Ishikawa N, Yoshiyama T, Uchimura K, Aoki M, Mori T. Current epidemiological trend of tuberculosis in Japan. Int J Tuberc Lung Dis. 2002;6(5):415-23.
17. Kiyohara T, Sato T, Totsuka A, Miyamura T, Ito T, Yoneyama T. Shifting seroepidemiology of hepatitis A in Japan, 1973-2003. Microbiol Immunol. 2007;51(2):185-91.
18. Ishii A, Tsuji M, Tada I. History of Katayama disease: Schistosomiasis japonica in Katayama district, Hiroshima, Japan. Parasitol Int. 2003;52(4):313-9.
19. Nakagomi T, Itaya H, Tominaga T, Yamaki M, Hisamatsu S, Nakagomi O. Is atopy increasing? Lancet. 1994;343(8889):121-2.
20. Holdsworth SR, Kitching AR, Tipping PG. Th1 and Th2 T helper subsets affect patterns of injury and outcomes in glomerulonephritis. Kidney Int. 1999;55(4):1198-216.